Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea (Q43806478)

27 November 2017

Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea (English)

1 reference

27 November 2017

1 reference

Pack AI

1

1 reference

27 November 2017

Black JE

series ordinal

2

1 reference

27 November 2017

Schwartz JR

series ordinal

3

1 reference

27 November 2017

Matheson JK

series ordinal

4

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

American Journal of Respiratory and Critical Care Medicine

27 November 2017

1 reference

27 November 2017

164

1 reference

27 November 2017

1675-1681

1 reference

27 November 2017

9

1 reference

The occurrence of sleep-disordered breathing among middle-aged adults

27 November 2017

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

Severe obstructive sleep apnea--II: Associated psychopathology and psychosocial consequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

Association of sleep apnoea with myocardial infarction in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

Daytime sleepiness and vascular morbidity at seven-year follow-up in obstructive sleep apnea patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

Cardiopulmonary consequences of obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

Increased mortality among sleepy snorers: a prospective population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

Prospective study of the association between sleep-disordered breathing and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

The association between sleep apnea and the risk of traffic accidents. Cooperative Group Burgos-Santander.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

Automobile accidents in patients with sleep apnea syndrome. An epidemiological and mechanistic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

Habitually sleepy drivers have a high frequency of automobile crashes associated with respiratory disorders during sleep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

Indications for positive airway pressure treatment of adult obstructive sleep apnea patients: a consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep Apnea/Hypopnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

Improvement of mild sleep-disordered breathing with CPAP compared with conservative therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

Predictors of improvements in daytime function outcomes with CPAP therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

Effects of one night without nasal CPAP treatment on sleep and sleepiness in patients with obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

Persistent neuropsychological deficits and vigilance impairment in sleep apnea syndrome after treatment with continuous positive airways pressure (CPAP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

Recovery of alertness after CPAP in apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

Daytime sleepiness after long-term continuous positive airway pressure (CPAP) treatment in obstructive sleep apnea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

A randomized trial of the long-term, continued efficacy and safety of modafinil in narcolepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

Long-term efficacy and safety of modafinil (PROVIGIL((R))) for the treatment of excessive daytime sleepiness associated with narcolepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

Modafinil, d-amphetamine and placebo during 64 hours of sustained mental work. II. Effects on two nights of recovery sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

Evaluation of the abuse liability of modafinil and other drugs for excessive daytime sleepiness associated with narcolepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

Does short-term treatment with modafinil affect blood pressure in patients with obstructive sleep apnea?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

Sensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wakefulness test and the epworth sleepiness scale: failure of the MSLT as a gold standard

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

Effects of humidification on nasal symptoms and compliance in sleep apnea patients using continuous positive airway pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

Interobserver variability in recognizing arousal in respiratory sleep disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

Variation in the arousal pattern after obstructive events in obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

What is hypopnea, anyway?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

A comparison of apnea-hypopnea indices derived from different definitions of hypopnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea/hypopnea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

Can intensive support improve continuous positive airway pressure use in patients with the sleep apnea/hypopnea syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

Development of nocturnal respiratory disturbance in untreated patients with obstructive sleep apnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

Natural evolution of moderate sleep apnoea syndrome: significant progression over a mean of 17 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

Sleep apnea and hypertension. A population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2103032

10.1164/AJRCCM.164.9.2103032

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference